scholarly journals Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*)

Author(s):  
Rita Quelhas da Costa ◽  
Francisco Laranjeira ◽  
Isaura Duarte Ribeiro ◽  
António Filipe Santos ◽  
Filipe Nery

Metabolic associated fatty liver disease became the most common form of chronic liver disease, in the vast majority of the cases related to increased insulin resistance or metabolic dysregulation. Yet, other causes may be implied. We report the late diagnosis of Dorfman-Chanarin syndrome in a non-alcoholic steatohepatitis previously labeled cirrhotic middle-aged man, with consanguineous parents, complicated with hepatocellular carcinoma. Congenital ichthyosis, neurosensory hearing loss and elevated muscular enzymes hit on the track of Dorfman-Chanarin syndrome. The genetic analysis uncovered a first-time described homozygotic nonsense mutation in the <i>ABHD5</i> gene, responsible for coding the ABHD5 protein. The patient was successfully submitted to liver transplantation. Inborn errors of metabolism are a rare cause of metabolic associated fatty liver disease, but they need to be kept in consideration in all patients who present with atypical clinical features. This shall raise the awareness of physicians to rare forms of presentation since it may imply not only a different prognosis, but also other actions, like particular therapies as liver transplantation due to related complications of cirrhosis, or familial screening.

2022 ◽  
Vol 8 ◽  
Author(s):  
Speranta Iacob ◽  
Susanne Beckebaum ◽  
Razvan Iacob ◽  
Cristian Gheorghe ◽  
Vito Cicinnati ◽  
...  

Recurrent or de novo non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) following liver transplantation (LT) is a frequent event being increasingly recognized over the last decade, but the influence of recurrent NASH on graft and patient outcomes is not yet established. Taking into consideration the long term survival of liver transplanted patients and long term complications with associated morbidity and mortality, it is important to define and minimize risk factors for recurrent NAFLD/NASH. Metabolic syndrome, obesity, dyslipidemia, diabetes mellitus are life style risk factors that can be potentially modified by various interventions and thus, decrease the risk of recurrent NAFLD/NASH. On the other hand, genetic factors like recipient and/or donor PNPLA3, TM6SF2, GCKR, MBOAT7 or ADIPOQ gene polymorphisms proved to be risk factors for recurrent NASH. Personalized interventions to influence the different metabolic disorders occurring after LT in order to minimize the risks, as well as genetic screening of donors and recipients should be performed pre-LT in order to achieve diagnosis and treatment as early as possible.


2021 ◽  
Vol 13 (12) ◽  
pp. 1991-2004
Author(s):  
Ma Ai Thanda Han ◽  
Raquel Olivo ◽  
Catherine J Choi ◽  
Nikolaos Pyrsopoulos

2019 ◽  
Vol 25 (1) ◽  
pp. 56-67 ◽  
Author(s):  
Zita Galvin ◽  
Ramraj Rajakumar ◽  
Emily Chen ◽  
Oyedele Adeyi ◽  
Markus Selzner ◽  
...  

PLoS ONE ◽  
2019 ◽  
Vol 14 (11) ◽  
pp. e0224820 ◽  
Author(s):  
Denisa Erhartova ◽  
Monika Cahova ◽  
Helena Dankova ◽  
Marie Heczkova ◽  
Irena Mikova ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document